Bill > AB641

This bill establishes a Drug-Induced Movement Disorder Awareness Program to be developed and administered by the State Department of Public Health by January 1, 2028. The program aims to raise awareness about drug-induced movement disorders (involuntary movements caused by medications that control dopamine, such as antipsychotics used to treat mental health conditions like schizophrenia and bipolar disorder) by providing evidence-based educational information about screening, identifying symptoms, and understanding risk factors. The bill seeks to reduce stigma surrounding these disorders by educating health professionals, public safety officials, and the community about the uncontrollable physical symptoms that can result from mental health medications. The program will include educational resources about the importance of identifying symptoms of drug-induced movement disorders like tardive dyskinesia, which can cause persistent, irreversible involuntary movements. The department may consult with other state health agencies in implementing the program, and the initiative is set to remain in effect until January 1, 2032, after which it will be automatically repealed. The bill emphasizes the importance of periodic screenings and understanding these disorders to improve patient outcomes and reduce misunderstandings about these medical conditions.

Budget and Finance, Health and Social Services

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260AB641